Additionally, research concerning LPCAT1 and LPCAT2 gene expression in CRSwNP should be performed to confirm whether these gene expressions are indeed good biomarkers for the severity of type 2 inflammation. This evidence concerns the gene LPCAT2 and chronic rhinosinusitis with nasal polyps.